Keith Q. Tanis

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies”.

A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies

Toxicological Sciences(2022)10.1093/toxsci/kfac041

N/A

0DataRank · unranked

21 citations

Constance A. Mitchell, Scott S. Auerbach, Pierre R. Bushel, Heidrun Ellinger‐Ziegelbauer, Patricia A. Escobar +14 more